Objective. Bone mineral density (BMD) in later life is a major determinant of osteoporotic fracture risk and has been shown to be under strong genetic in¯uence. Transforming growth factor b1 (TGF-b1) is an important regulatory cytokine, is found in high concentrations in the bone matrix, and is a plausible candidate for the genetic regulation of BMD.
Osteoporosis is a common age-related condition and is characterized by reduced bone mineral density (BMD), deterioration in skeletal microarchitecture and an increased risk of fragility fracture w1x. BMD is the strongest predictor of fracture w2x, and a large number of twin and family studies have suggested a strong genetic in¯uence on this trait, up to 85% of the population variance in BMD being attributable to genetic factors w3±5x.
Over the last few years a number of genes have been implicated as having a potential role in the determination of BMD and the risk of osteoporotic fracture w6x. Most of these studies have been associationbased in either patient groups or general population cohorts, and have examined polymorphisms within candidate genes of interest. More recently, genome-wide searches have been performed in sib-pairs, positive linkage results identifying chromosomal regions that may harbour novel quantitative trait loci w7x. Although association analyses are generally more powerful than linkage analyses in the identi®cation of loci having modest effects on complex traits w8x, results may be affected by population strati®cation or admixture w9x.
To overcome some of these problems, the transmission disequilibrium test (TDT) has been developed w10x and has recently been modi®ed for the analysis of sibling-only data and of quantitative traits w11, 12x.
In this analysis, the transforming growth factor b1 gene (TGF-b1) was examined as a potential candidate gene for the determination of osteoporosis in nonidentical, dizygous (DZ) twins. The aim of the study was to examine the regulatory and coding regions of the TGF-b1 gene for novel genetic variation and to assess the relationship between any novel polymorphisms and bone mass at multiple skeletal sites. By using twin pairs, it was possible to perform association analysis across the twin pairs, with subsequent TDT analysis within the DZ pairs to con®rm any initial positive ®ndings.
Methods

Subjects
The subjects studied were Caucasian female DZ twins (age range 18±76 yr), recruited after national media campaigns. All subjects were healthy and did not suffer from diseases speci®cally affecting bone, and were broadly representative of the normal UK population, as described previously w13x. The twins completed a nurse-administered questionnaire detailing medical, obstetric and gynaecological histories, full drug histories, dietary assessment and smoking status. The zygosity of the twins was determined by questionnaire and in doubtful cases this was con®rmed by multiplex DNA ®ngerprinting. Post-menopausal status was de®ned as the absence of menstruation for at least 12 months and was con®rmed by measurement of serum sex hormone levels.
Measurements
BMD was measured at the lumbar spine (L1±4), non-dominant hip (femoral neck, total hip), and nondominant ultradistal radius using dual-energy X-ray absorptiometry on a Hologic QDR-2000 (Hologic, Waltham, Massachusetts, USA). Reproducibility, as assessed by the coef®cient of variation from duplicate measures in healthy volunteers, was between 0.8 and 1.6% at the skeletal sites measured. Subjects were classi®ed as having osteoporosis according to the World Health Organization diagnostic criteria if their BMD measurement was 2.5 standard deviations (S.D.) below the mean peak young adult value (i.e. a T-score less than À 2.5)
Calcaneal ultrasound was measured using a McCue Cuba Clinical scanner. This produced two output variables: broadband ultrasound attenuation (BUA) and velocity of sound (VOS). Reproducibility, as assessed by the coef®cient of variation in duplicate measures on 30 subjects, was 2.5% (BUA) and 0.44% (VOS).
Identi®cation of polymorphisms DNA was prepared for each subject from peripheral blood leucocytes using a standard phenol extraction method. Common single-nucleotide polymorphisms (SNPs) in the TGF-b1 gene were detected by sequence analysis of 24 unrelated DZ individuals and comparison was made with the published TGF-b1 sequence (accession no. Y00112) w14, 15x. This strategy was chosen in order to identify polymorphisms with an allele frequency of at least 0.1 within the study group. Oligonucleotide primer pairs were designed to cover the TGF-b1 coding regions, and the promoter and 59-untranslated region up to position ±1363. After ampli®cation of the DNA by the polymerase chain reaction (PCR), the products were puri®ed, sequenced using dRhodamine Terminator cycle sequencing, and analysed on an ABI 377 DNA sequencer (Perkin Elmer Applied Biosystems, Foster City, California, USA).
Restriction enzyme digestion
Polymorphism screening within the DZ group was performed using PCR±restriction fragment length polymorphism (RFLP)-based methods. DNA samples from subjects with known genotype were included as positive controls. Two PCR±RFLP assays were used in this study.
BstUI PCR±RFLP analysis of the intron 5 SNP PCR ampli®cation was performed using the oligonucleotide primers 59-ATGGTGGTAGCCCCTCCCT-39 and 59-GCATCTCGTAGCCCGGTGG-39. Reactions were performed in 25 ml, with the following composition: 0. StuI PCR±RFLP analysis of the codon 255 SNP PCR was performed as described above, except that the oligonucleotide primers used were 59-ACTGCTC-CTGTGACAGCAG-39 and 59-ATCCAGGCTACA-AGGCTCAC-39 and the annealing temperature was reduced from 60 to 558C. Digestion of the 354 bp PCR product was performed with 3 units of StuI (New England Biolabs) at 378C for 2 h.
Statistical analysis
All analyses testing for the effects of the TGF-b1 intron 5 polymorphism were done within a structural equation modelling framework using Mx software w16x. Parameters were estimated by normal-theory maximum likelihood, in which the models were ®tted to the raw data w16, 17x.
Test for association
A full model was speci®ed, which estimated means (and their 95% con®dence intervals) for each of the possible genotypes (A1A1, A1A2 and A2A2) and the residual sib-pair variance±covariance matrix, thereby taking account of the relatedness between the sibs. The effect of the TGF-b1 intron5 polymorphism was assessed by comparing the full model, in which the means were estimated separately for each genotype (i.e. mA1A1 /mA1A2/mA2A2), with the reduced model, in which the means were constrained to be equal across genotypes (i.e. mA1A1smA1A2smA2A2). This gives a x 2 test with 2 degrees of freedom (d.f.), since the difference between minus twice the log-likelihood ( À 2 lnL) for a reduced model and that of the full model is approximately distributed as x 2 , with d.f. equal to the difference in the number of parameters estimated in the full and reduced models. The effect of potential confounding variables was accommodated in the model by incorporating the effect of age and menopausal status as a linear regression on the trait value. Comparison of the residual variances in the full and reduced models also enabled us to estimate the percentage of the variation in the trait that was explained by the TGF-b1 intron 5 locus. The analytical approach described above is similar to one used and described previously w18x.
Test for sibship transmission disequilibrium
To test whether any signi®cant associations might have been due to population strati®cation or admixture, signi®cant results were followed up with a sibship TDT (s-TDT) for quantitative traits. We adapted the TDT described for the situation of sib-pairs only w19x, which provides a test for linkage in the presence of association. This test is essentially the same as that described by Fulker et al. w12x and explores the fact that population admixture can only result in differences between sib-pairs, not within sib-pairs. Testing whether within-sib-pair differences in the trait can be explained by the locus therefore makes the s-TDT insensitive to the effects of population admixture.
For the s-TDT, the locus effect on the trait was modelled using parameterization in which a score a is assigned to A1A1 subjects, d to A1A2 subjects, and À a to A2A2 subjects (Table 1) w20x. The last two columns of Table 1 list the deviations from the sib-pair means that are used by the s-TDT to model the within-sib-pair differences due to the locus. It must be noted that only sib-pairs discordant for their genotype are informative for the s-TDT, which can be seen in Table 1 . The effect of confounders was again incorporated in the model by including the effects of age and menopausal status as a linear regression on the trait value. For the s-TDT, the effect of the locus was tested by comparing the full model, in which the parameters a and d were estimated, with the reduced model, in which the effect of both a and d was set to zero, which gives a x 2 test with 2 d.f.
Results
Sequence analysis of 24 unrelated individuals identi®ed two novel polymorphisms in the TGF-b1 gene in addition to six previously identi®ed polymorphisms within the 59 and coding regions w21x. The two novel polymorphisms included a C£A substitution at codon 255 and a T£C substitution in intron 5 (20 bp upstream of exon 6). The ®rst substitution in codon 255 represented a synonymous codon change (CCG to AGG) and had no effect on the amino acid sequence at this point (arginine). Subsequent testing of this polymorphism using a StuI PCR±RFLP showed, however, that this allelic variant was very rare, as it was identi®ed in only one of the 400 subjects tested. The polymorphic T£C substitution in intron 5 introduces a BstUI site (recognition sequence 59-CG £CG-39), and subsequent screening for this within the whole DZ cohort using the BstUI PCR±RFLP showed the allele frequencies to be 0.75(T) and 0.25(C), the genotype distributions being in Hardy±Weinberg equilibrium (x 2 s1.21, P ) 0.05). In total, phenotypic data were available on 1706 DZ subjects (853 pairs). Intron 5 genotype results were available for 1501 (88%) of the DZ subjects. Reasons for the absence of genetic results included inadequate DNA extraction and failure of the PCR±RFLP assay. Because no signi®cant differences were observed between subjects with and without TGF-b1 genotype results, no attempt was made to repeat the genotype analysis on this subset. Characteristics of the study population are shown in Table 2 . There were no statistically signi®cant differences in height, weight, smoking status or hormone replacement therapy (HRT) use between the 
three TGF-b1 intron 5 genotype groups. There were, however, small differences in the ages and the proportion of post-menopausal women between these groups, although these were not statistically signi®cant ( Table 2 ). The TGF-b1 intron 5 genotype A2A2 was associated with hip BMD when compared with the other genotypes within the whole study population, with a 4% reduction in femoral neck BMD (P -0.025) and a 2.4% reduction in total hip BMD, although the latter did not reach signi®cance ( Table 3 ). The effect on femoral neck BMD remained signi®cant after adjustment for menopausal status and age, with a x 2 value of 6.53 (Ps0.038). The hip BMD data were normally distributed around each genotype. No genotypic association was seen at the lumbar spine, ultradistal radius or with the calcaneal ultrasound parameters of BUA and VOS. The proportion of the population variance in femoral neck BMD explained by the intron 5 TGF-b1 polymorphism was estimated to be 0.43%.
To ensure sure that these results did not merely re¯ect the higher proportion of post-menopausal women in the A2A2 group, we conducted a strati®ed analysis of twin pairs who were either both pre-menopausal or postmenopausal. The upper part of Table 4 (Association test) shows that the effect of the polymorphism was especially apparent in pre-menopausal twins, in whom it explained 0.87% of the population variance. However, the effect did not reach statistical signi®cance in postmenopausal twins, in whom it explained only 0.67% of the trait variance. Adjustment for age did not change these results.
Overall, the prevalence of clinically de®ned osteoporosis (T-score less than À 2.5) at the femoral neck in the genotype group A2A2 was 15.5% compared with 9.9% in each of the A1A1 and A1A2 groups. The A2A2 genotype group tended to an increased risk of having osteoporosis at the femoral neck compared with the other two genotypes, with an odds ratio (95% con®dence interval) of 1.69 (0.94, 3.04) (Ps0.08). Similarly, this relationship was most apparent in pre-menopausal women, in whom the A2A2 genotype group had a greater than 5-fold increased risk, with an odds ratio of 5.38 (1.96, 14.89). In the post-menopausal twin pairs there was no increase in risk, with an odds ratio of 1.09 (0.52, 2.56).
The s-TDT was subsequently used to test whether the association between the TGF-b1 intron 5 locus and femoral neck BMD was real or whether it might have been due to population strati®cation. The results are shown in the lower part of Table 4 (s-TDT). In spite of the reduced power resulting from the loss of noninformative sib-pairs, who constituted more than 50% of the total sample, the effect of the locus remained highly signi®cant and was not affected by adjustment for age and menopausal status. The strati®ed analysis also con®rmed the difference in the effect of the locus between pre-and post-menopausal individuals.
Discussion
In this study we have identi®ed a T£C polymorphism in intron 5 of the human TGF-b1 gene. The data demonstrate both association and linkage disequilibrium between this polymorphism and hip BMD in a large group of unselected, normal female DZ twins. The C allele was present at a frequency of 0.25 in the twin population, and there appeared to be a recessive pattern of risk associated with this allelic variant. Hip BMD was up to 4% lower in women who were homozygous for the allele compared with women who were either heterozygous or homozygous for the commoner allele. Overall, women who were homozygous for the polymorphism tended to have an increased risk of having osteoporosis at the femoral neck in comparison with the other two genotypes. Strati®cation of results by menopausal status demonstrated that the signi®cant ®ndings were predominantly observed in the pre-menopausal subjects. The observation that these ®ndings were con®ned to the hip (and predominantly at the femoral neck) rather than being seen at the spine and distal radius suggests a site-speci®c association. The absence of any association of genotype with bone ultrasound measures also suggests that the TGF-b1 intron 5 polymorphism has a predominant effect on BMD rather than on bone quality or structure. Modelling of data in twins has suggested that there are both common and speci®c genetic factors acting on bone at different skeletal sites and on different aspects of bone quality w22x. There are also data from animal models of osteoporosis suggesting that the effect of genes may be site-speci®c w23x. The ®nding that the relationship between the intron 5 genotype and BMD was strongest in pre-menopausal women suggests an in¯uence of this genotype on the attainment of peak BMD, and is of interest as the action of TGF-b1 on bone is mediated via oestrogen w24, 25x.
The TGF-b1 gene has also been associated with the risk of osteoporosis in other studies. A recent study has also identi®ed a further novel polymorphism in intron 4 of the TGF-b1 gene (a C deletion 8 bp upstream of exon 5) w26x. This polymorphism was rare (technically it is a mutation), being present in only 10 of 161 osteoporotic patients with spinal fracture (allele frequency 0.03) and two of 131 controls (allele frequency 0.008). Although there was no overall signi®cant association between this polymorphism and BMD, subgroup analysis in patients with both spinal fracture and low BMD (de®ned as Z-score less than À 1) did show an association with carriage of the polymorphic allele and BMD at the spine only. In 287 Japanese postmenopausal women, a T£C polymorphism at codon 10 was associated with spinal BMD and risk of vertebral fracture w27x. In addition, an association between circulating levels of serum TGF-b1 was also observed. The À 509 promoter polymorphism has also been shown to be associated with serum TGF-b1 levels w18x, although the serum levels did not appear to correlate with BMD w28x.
These data illustrate the candidacy of the TGF-b1 locus, although they highlight the dif®culties of interpreting results when allelic variants are examined in isolation. It is becoming apparent from other disease areas that full characterization and testing of all singlenucleotide polymorphisms in genes may be required to detect disease-related alleles w29, 30x. Earlier work has also identi®ed strong linkage disequilibrium across the TGF-b1 gene w21x, thereby suggesting that the construction and examination of haplotypes would be possible with additional polymorphism information. Unfortunately, in this study we had full coding sequence data available on only 24 subjects (i.e. 48 chromosomes), and this was too small for the estimation of linkage disequilibrium or for the construction of haplotypes.
The study has potential limitations in addition to those previously addressed. The proportion of population variance in BMD attributable to the TGF-b1 polymorphism appears small (-1%), probably re¯ect-ing the fact that the risk associated with this locus was apparent only in the rare homozygous CC genotype group. This, however, highlights the power of association studies in large numbers of subjects to detect loci having modest effects on trait values. In addition, loci having only small effects on BMD may still have important in¯uences on the risk of fracture, as illustrated by recent ®ndings about the type I collagen 1a gene and osteoporosis w31x. In this study, the polymorphic s allele was associated with a 2-fold increased risk of fracture despite explaining only 0.3 and 0.4% of the population variance in BMD at the hip and spine respectively. The functional signi®cance of our ®ndings with an intronic polymorphism on TGF-b1 activity is also uncertain, although as it is located 20 bp upstream of exon 6 it could have some in¯uence on the active component of the TGF-b1 protein. It has been reported that up to 15% of human diseases are caused by point-sequence variation in splice regions, resulting in either exon-skipping or cryptic splicing w32x, and although the intron 5 polymorphism is not located in a splice donor or acceptor site it could affect a branch point. The intronic polymorphic sequence change may also affect messenger RNA stability. If the intron 5 polymorphism is not functional, then the results from the s-TDT would suggest that the TGF-b1 polymorphism is actually in linkage disequilibrium with a novel disease locus mapping to this chromosomal region. Given the strong linkage disequilibrium across the TGF-b1 gene, this suggests that other sequence variation within the gene should be examined. In addition, other loci mapping to within 1±2 cM (centimorgans) of the TGF-b1 on chromosome 19q13 should also be examined. The use of twins and the applicability of the ®ndings to the wider population is also sometimes questioned. However, the DZ twins in this study had baseline characteristics similar to those of women from the UK population, and we believe that our results will be applicable to unrelated individuals. DZ twins also offer advantages for the genetic analysis of complex, age-related traits such as osteoporosis, particularly the matching for age and shared environment. Statistical analysis both across and within DZ pairs also offers advantages in the power to detect loci having modest effects on disease risk w33x. In summary, this study has identi®ed additional and novel sequence variation in the TGF-b1 gene. A T£C polymorphism in intron 5 of the TGF-b1 gene has shown an association with femoral neck BMD in a large group of normal DZ female twins. Subjects who were homozygous for the polymorphic allele had reduced BMD and an increased risk of osteoporosis at the hip. The demonstration of linkage disequilibrium through the use of the s-TDT within the twins also con®rms the candidacy of this locus as having signi®cant effects on the genetic determination of hip BMD. The effects attributable to this genotype were seen predominantly in pre-menopausal rather than post-menopausal women, suggesting that this locus may have some in¯uence either on the attainment of peak BMD or on differential rates of post-menopausal bone loss. Further studies are required to con®rm these ®ndings and to determine the effect of this locus on the risk of future fractures. The study also highlights the power of candidate gene analysis in twins, in whom loci having modest effects on disease risk can be identi®ed.
